Published in Biochem Biophys Res Commun on October 04, 1995
CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J (2002) 6.83
CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol (1998) 3.19
Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol (2008) 1.61
C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol (2004) 1.21
Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPalpha. Nucleic Acids Res (1998) 1.17
Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Am J Pathol (1997) 1.06
Gene mutations and molecularly targeted therapies in acute myeloid leukemia. Am J Blood Res (2013) 0.95
Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line. BMC Cancer (2006) 0.89
Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590. Lung Cancer (2007) 0.89
Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein. J Virol (2015) 0.87
CCAAT/enhancer binding protein epsilon: changes in function upon phosphorylation by p38 MAP kinase. Blood (2005) 0.85
A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia. J Mol Diagn (2009) 0.82
CCAAT/enhancer binding protein β in relation to ER stress, inflammation, and metabolic disturbances. Biomed Res Int (2015) 0.80
Editorial: granulopoiesis versus monopoiesis: a consequence of transcription factors dancing with the right partners. J Leukoc Biol (2011) 0.75
A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood. Oncogene (2017) 0.75
CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells. Oncol Lett (2017) 0.75
Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem (1998) 3.93
A liver-specific DNA-binding protein recognizes multiple nucleotide sites in regulatory regions of transthyretin, alpha 1-antitrypsin, albumin, and simian virus 40 genes. Proc Natl Acad Sci U S A (1988) 2.71
Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha. J Biol Chem (1996) 2.47
A direct role for C/EBP and the AP-I-binding site in gene expression linked to adipocyte differentiation. Mol Cell Biol (1989) 2.33
Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci U S A (1997) 2.14
Molecular cloning, cDNA sequencing, and chemical synthesis of cecropin B from Hyalophora cecropia. Proc Natl Acad Sci U S A (1985) 1.85
One factor recognizes the liver-specific enhancers in alpha 1-antitrypsin and transthyretin genes. Science (1988) 1.78
A cell-specific enhancer of the mouse alpha 1-antitrypsin gene has multiple functional regions and corresponding protein-binding sites. Mol Cell Biol (1988) 1.61
CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A (1997) 1.50
High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors. Nucleic Acids Res (1993) 1.38
Targeted expression of Cre recombinase to adipose tissue of transgenic mice directs adipose-specific excision of loxP-flanked gene segments. Nucleic Acids Res (1997) 1.29
CCAAT/enhancer binding protein epsilon is critical for effective neutrophil-mediated response to inflammatory challenge. Blood (1999) 1.29
Analysis by in situ hybridization of cells expressing mRNA for interleukin 4 in the developing thymus and in peripheral lymphocytes from mice. Proc Natl Acad Sci U S A (1988) 1.21
Insect immunity. Isolation and sequence of two cDNA clones corresponding to acidic and basic attacins from Hyalophora cecropia. EMBO J (1984) 1.20
Differential patterns of expression of three C/EBP isoforms, HNF-1, and HNF-4 after partial hepatectomy in rats. Exp Cell Res (1993) 1.12
On the primary structures of lysozyme, cecropins and attacins from Hyalophora cecropia. Dev Comp Immunol (1985) 1.08
Fetal and adult localization of C/EBP: evidence for combinatorial action of transcription factors in cell-specific gene expression. Development (1990) 1.05
CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis (Review). Int J Mol Med (1998) 1.05
Amino acid and cDNA sequences of lysozyme from Hyalophora cecropia. EMBO J (1985) 1.01
Transcriptional control in hepatocytes of normal and c14CoS albino deletion mice. EMBO J (1992) 0.94
Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members. Oncogene (1996) 0.92
Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region. Eur J Biochem (1995) 0.92
Suicide gene therapy for plasma cell tumors. Blood (1996) 0.90
Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Mol Carcinog (1995) 0.90
Hepatocytes deficient in CCAAT/enhancer binding protein alpha (C/EBP alpha) exhibit both hepatocyte and biliary epithelial cell character. Biochem Biophys Res Commun (1998) 0.90
Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA. J Neurosurg (2001) 0.86
Differential adrenergic regulation of C/EBP alpha and C/EBP beta in brown adipose tissue. FEBS Lett (1993) 0.86
Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus. Cancer Gene Ther (2001) 0.83
Hunting with traps: genome-wide strategies for gene discovery and functional analysis. Genome Res (1999) 0.83
Synergistic activation of the human Btk promoter by transcription factors Sp1/3 and PU.1. Biochem Biophys Res Commun (1999) 0.81
Insect immunity--a gene system for antibacterial proteins. Mem Inst Oswaldo Cruz (1987) 0.79
Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells. Hum Gene Ther (1997) 0.78
Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12. Neurosurg Focus (2000) 0.78
Retroviral-mediated gene transfer into human myeloma cells. Br J Haematol (1994) 0.77
Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression. Gene Ther (1998) 0.76
Retroviral-mediated gene transfer into human bone marrow stromal cells: studies of efficiency and in vivo survival in SCID mice. Eur J Haematol (1995) 0.76
Retroviral-mediated gene transfer of CD34-enriched bone marrow and peripheral blood cells during autologous stem cell transplantation for multiple myeloma. Hum Gene Ther (1994) 0.75
Basic fibroblast growth factor increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cells. Exp Hematol (1994) 0.75
Developing targets for drug discovery using genome-wide gene trapping and ultra-sensitive beta-lactamase reporters. Proc West Pharmacol Soc (1999) 0.75